Centessa Pharmaceuticals (CNTA) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Centessa Pharmaceuticals (CNTA).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Jan 29, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||||||
Total Revenue | - | - | - | - | 15M | - | - | - | - | 6.85M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | ||||||||||||||||||||||||||
Research And Development | 60M (+9.93%) | 54M (+31.09%) | 42M (-2.76%) | 43M (+27.81%) | 33M (-45.06%) | 61M (+79.56%) | 34M (+3.29%) | 33M (+44.90%) | 23M (-23.79%) | 30M (+5.43%) | 28M (-16.28%) | 34M (+2.56%) | 33M (+17.92%) | 28M (-24.22%) | 37M (-31.52%) | 54M (+45.59%) | 37M (-11.27%) | 42M (+60.66%) | 26M (+42.58%) | 18M (+78.80%) | 10M | -3.13M | 5.51M (+186.98%) | 1.92M (+2.67%) | 1.87M | - |
Selling General And Administrative | 20M (+42.00%) | 14M (+14.47%) | 12M (+2.69%) | 12M (-3.41%) | 12M (-10.07%) | 14M (+9.68%) | 13M (+11.91%) | 11M (-16.89%) | 13M (+9.09%) | 12M (+2.50%) | 12M (-9.96%) | 13M (-16.82%) | 16M (+16.56%) | 14M (+12.13%) | 12M (-16.80%) | 15M (+2.57%) | 14M (+10.78%) | 13M (+4.25%) | 12M (+5.24%) | 12M (+111.43%) | 5.60M | -330.00K | 690K (+263.16%) | 190K (-26.92%) | 260K | - |
Operating Expenses | 80M (+16.50%) | 68M (+27.29%) | 54M (-1.57%) | 55M (+19.38%) | 46M (-38.62%) | 75M (+60.70%) | 46M (+5.53%) | 44M (+21.86%) | 36M (-14.13%) | 42M (+4.53%) | 40M (-14.48%) | 47M (-3.81%) | 49M (+17.50%) | 42M (-15.15%) | 49M (-28.33%) | 68M (+33.51%) | 51M (-6.02%) | 55M (+42.31%) | 38M (+27.79%) | 30M (+90.47%) | 16M | -3.46M | 6.20M (+192.45%) | 2.12M (-0.47%) | 2.13M | - |
Depreciation And Amortization | 240K (-65.71%) | 700K | - | - | 220K (-68.57%) | 700K | - | - | 240K (-66.67%) | 720K | - | - | 90K (-10.00%) | 100K | - | - | 30K (+200.00%) | 10K (-50.00%) | 20K (+100.00%) | 10K | - | - | - | - | - | - |
Operating Income | ||||||||||||||||||||||||||
Operating Income | -79.77M (+16.50%) | -68.47M (+27.29%) | -53.79M (-1.57%) | -54.65M (+77.55%) | -30.78M (-58.73%) | -74.58M (+60.73%) | -46.40M (+5.50%) | -43.98M (+21.86%) | -36.09M (+2.59%) | -35.18M (-12.51%) | -40.21M (-14.48%) | -47.02M (-3.81%) | -48.88M (+17.50%) | -41.60M (-15.15%) | -49.03M (-28.33%) | -68.41M (+28.54%) | -53.22M (-8.70%) | -58.29M (+52.15%) | -38.31M (-7.22%) | -41.29M (-82.52%) | -236.19M | 3.46M | -6.19M (+191.98%) | -2.12M (-0.47%) | -2.13M | - |
Ebit | -79.77M (+16.50%) | -68.47M (+27.29%) | -53.79M (-1.57%) | -54.65M (+77.55%) | -30.78M (-58.73%) | -74.58M (+60.73%) | -46.40M (+5.50%) | -43.98M (+21.86%) | -36.09M (+2.59%) | -35.18M (-12.51%) | -40.21M (-14.48%) | -47.02M (-3.81%) | -48.88M (+17.50%) | -41.60M (-15.15%) | -49.03M (-28.33%) | -68.41M (+28.54%) | -53.22M (-8.70%) | -58.29M (+52.15%) | -38.31M (-7.22%) | -41.29M (-82.52%) | -236.19M | 6.47M | -3.18M (+50.00%) | -2.12M (-0.47%) | -2.13M (-29.24%) | -3.01M |
EBITDA | -79.53M (+2.37%) | -77.69M (+49.89%) | -51.83M (+11.03%) | -46.68M (+52.75%) | -30.56M (-63.74%) | -84.28M (+113.91%) | -39.40M (-2.93%) | -40.59M (+13.22%) | -35.85M (-1.13%) | -36.26M (-6.86%) | -38.93M (-16.26%) | -46.49M (-4.71%) | -48.79M (+11.34%) | -43.82M (-15.88%) | -52.09M (-17.36%) | -63.03M (+18.50%) | -53.19M (-8.73%) | -58.28M (+52.17%) | -38.30M (-7.22%) | -41.28M (-82.52%) | -236.19M | 6.59M | -3.06M (+42.99%) | -2.14M (-4.04%) | -2.23M (-25.91%) | -3.01M |
Other Income / Expenses | ||||||||||||||||||||||||||
Interest Income | 5.14M (+14.48%) | 4.49M (+19.10%) | 3.77M (-13.93%) | 4.38M (-44.49%) | 7.89M (+62.68%) | 4.85M (+45.21%) | 3.34M (+3.09%) | 3.24M (+25.10%) | 2.59M (-52.56%) | 5.46M (+85.08%) | 2.95M (+43.20%) | 2.06M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense | 2.73M (-2.85%) | 2.81M (-2.77%) | 2.89M (+0.35%) | 2.88M (0.00%) | 2.88M (+16.13%) | 2.48M (-3.13%) | 2.56M (+1.19%) | 2.53M (0.00%) | 2.53M (-1.56%) | 2.57M (+1.18%) | 2.54M (+3.67%) | 2.45M (+4.26%) | 2.35M (+6.82%) | 2.20M (+14.58%) | 1.92M (+16.36%) | 1.65M (+10.00%) | 1.50M | - | - | - | - | - | - | - | - | - |
Net Interest Income | 5.14M (+14.48%) | 4.49M (+19.10%) | 3.77M (-13.93%) | 4.38M (-44.49%) | 7.89M (+7.06%) | 7.37M (+120.66%) | 3.34M (+3.09%) | 3.24M (+5300.00%) | 60K (-97.92%) | 2.89M (+604.88%) | 410K | -390.00K (-83.40%) | -2.35M (+6.82%) | -2.20M (+14.58%) | -1.92M (+16.36%) | -1.65M (+10.00%) | -1.50M | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | -1.02M | 2.91M | -1.81M | 3.59M (+248.54%) | 1.03M | -1.69M | 3.66M (+2340.00%) | 150K | -1.54M (-71.64%) | -5.43M (+223.21%) | -1.68M (+9.80%) | -1.53M (+13.33%) | -1.35M | 2.34M | -3.14M | 5.36M (+2580.00%) | 200K | -4.37M (+128.80%) | -1.91M (+905.26%) | -190.00K (-92.43%) | -2.51M | - | 160K (+1500.00%) | 10K | -10.00K | - |
Net Income | ||||||||||||||||||||||||||
Income Before Tax | -78.39M (+17.56%) | -66.68M (+21.86%) | -54.72M (+10.41%) | -49.56M (+100.32%) | -24.74M (-77.57%) | -110.28M (+162.82%) | -41.96M (-2.67%) | -43.11M (+14.78%) | -37.56M (+5.24%) | -35.69M (-13.94%) | -41.47M (-15.26%) | -48.94M (-2.20%) | -50.04M (+14.14%) | -43.84M (-18.84%) | -54.02M (-16.48%) | -64.68M (+18.85%) | -54.42M (-10.29%) | -60.66M (+51.08%) | -40.15M (-3.14%) | -41.45M (-82.63%) | -238.69M (+28657.83%) | -830.00K (-92.21%) | -10.66M | - | - | - |
Income Tax Expense | 850K | -520.00K | 170K (-78.21%) | 780K (-44.29%) | 1.40M (+33.33%) | 1.05M (+72.13%) | 610K (-14.08%) | 710K (+47.92%) | 480K (-57.89%) | 1.14M | -2.83M (-88.23%) | -24.05M | 680K | -660.00K (+371.43%) | -140.00K (+600.00%) | -20.00K | 80K (-27.27%) | 110K | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -79.24M (+19.77%) | -66.16M (+20.53%) | -54.89M (+9.04%) | -50.34M (+92.65%) | -26.13M (-76.53%) | -111.33M (+161.52%) | -42.57M (-2.85%) | -43.82M (+15.16%) | -38.05M (+3.28%) | -36.84M (-4.68%) | -38.65M (+55.28%) | -24.89M (-50.92%) | -50.71M (+17.47%) | -43.17M (-19.86%) | -53.87M (-16.69%) | -64.66M (+18.64%) | -54.50M (-10.32%) | -60.77M (+51.36%) | -40.15M (-3.14%) | -41.45M (-82.63%) | -238.69M | 6.55M | -3.29M (+53.74%) | -2.14M (-4.04%) | -2.23M (-25.91%) | -3.01M |
Net Income | -79.24M (+19.77%) | -66.16M (+20.53%) | -54.89M (+9.04%) | -50.34M (+92.65%) | -26.13M (-76.53%) | -111.33M (+161.52%) | -42.57M (-2.85%) | -43.82M (+15.16%) | -38.05M (+3.28%) | -36.84M (-4.68%) | -38.65M (+55.28%) | -24.89M (-50.92%) | -50.71M (+17.47%) | -43.17M (-19.86%) | -53.87M (-16.69%) | -64.66M (+18.64%) | -54.50M (-10.32%) | -60.77M (+51.36%) | -40.15M (-3.14%) | -41.45M (-82.63%) | -238.69M | 6.55M | -3.29M (+53.74%) | -2.14M (-4.04%) | -2.23M (-25.91%) | -3.01M |
Comprehensive Income Net Of Tax | -80.55M (-59.53%) | -199.03M (+269.39%) | -53.88M (+6.00%) | -50.83M (+79.80%) | -28.27M (-87.87%) | -233.04M (+453.93%) | -42.07M (-4.04%) | -43.84M (+15.61%) | -37.92M (-74.39%) | -148.09M (+281.58%) | -38.81M (+66.28%) | -23.34M (-53.15%) | -49.82M (-77.19%) | -218.39M (+301.23%) | -54.43M (-17.25%) | -65.78M (+19.17%) | -55.20M (-85.48%) | -380.29M (+835.75%) | -40.64M (+0.69%) | -40.36M (-82.93%) | -236.47M (+32743.06%) | -720.00K (-93.39%) | -10.90M (+515.82%) | -1.77M (-21.33%) | -2.25M | - |